Dataset from A Phase 3, Randomized, Multi-Center, Double-Blind, Parallel-Group, Placebo-Controlled Study of NRP104 in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder

NIAID Data Ecosystem2026-05-02 收录

ADHD药物

ADHD治疗

数据链接：

https://doi.org/10.25934/PR00008258 数据链接链接失效反馈

官方服务：

资源简介：

This study is designed to assess efficacy and safety of NRP-104 administered as a daily dose of 30mg, 50mg or 70mg compared to placebo in the treatment of children aged 6-12 years with ADHD.

创建时间：

2024-11-26

Dataset from A Phase 3, Randomized, Multi-Center, Double-Blind, Parallel-Group, Placebo-Controlled Study of NRP104 in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder

资源简介：

相关数据集